ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $17 | -5.6% | 30 | 0.0% | 0.00% | – |
| Q1 2021 | $18 | +80.0% | 30 | 0.0% | 0.00% | – |
| Q4 2020 | $10 | +66.7% | 30 | 0.0% | 0.00% | – |
| Q3 2020 | $6 | -57.1% | 30 | 0.0% | 0.00% | – |
| Q2 2020 | $14 | +27.3% | 30 | 0.0% | 0.00% | – |
| Q1 2020 | $11 | -85.1% | 30 | 0.0% | 0.00% | – |
| Q4 2019 | $74 | +29.8% | 30 | 0.0% | 0.00% | – |
| Q3 2019 | $57 | +67.6% | 30 | 0.0% | 0.00% | – |
| Q2 2019 | $34 | +9.7% | 30 | 0.0% | 0.00% | – |
| Q1 2019 | $31 | +24.0% | 30 | 0.0% | 0.00% | – |
| Q4 2018 | $25 | -35.9% | 30 | 0.0% | 0.00% | – |
| Q3 2018 | $39 | +129.4% | 30 | 0.0% | 0.00% | – |
| Q2 2018 | $17 | -45.2% | 30 | 0.0% | 0.00% | – |
| Q1 2018 | $31 | +10.7% | 30 | 0.0% | 0.00% | – |
| Q4 2017 | $28 | -34.9% | 30 | 0.0% | 0.00% | – |
| Q3 2017 | $43 | – | 30 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MITCHELL MCLEOD PUGH & WILLIAMS INC | 45,000 | $9,000 | 0.01% |
| Virtu Financial LLC | 134,296 | $27,000 | 0.01% |
| Sterling Investment Advisors, Ltd. | 40,000 | $8,000 | 0.00% |
| Sargent Investment Group, LLC | 16,750 | $3,000 | 0.00% |
| OPPENHEIMER & CO INC | 194,786 | $39,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 4,500 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 61,235 | $12,000 | 0.00% |
| AVANTAX ADVISORY SERVICES, INC. | 16,750 | $3,000 | 0.00% |
| MORGAN STANLEY | 38,072 | $8,000 | 0.00% |